PT2157973E - Medicamento compreendendo um derivado de carbostirilo e donepezilo para o tratamento da doença de alzheimer - Google Patents

Medicamento compreendendo um derivado de carbostirilo e donepezilo para o tratamento da doença de alzheimer Download PDF

Info

Publication number
PT2157973E
PT2157973E PT87647798T PT08764779T PT2157973E PT 2157973 E PT2157973 E PT 2157973E PT 87647798 T PT87647798 T PT 87647798T PT 08764779 T PT08764779 T PT 08764779T PT 2157973 E PT2157973 E PT 2157973E
Authority
PT
Portugal
Prior art keywords
donepezil
medicament
disease
treating alzheimer
carbostyril derivative
Prior art date
Application number
PT87647798T
Other languages
English (en)
Portuguese (pt)
Inventor
Heii Arai
Original Assignee
Otsuka Pharma Co Ltd
Univ Juntendo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Univ Juntendo filed Critical Otsuka Pharma Co Ltd
Publication of PT2157973E publication Critical patent/PT2157973E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT87647798T 2007-05-22 2008-05-21 Medicamento compreendendo um derivado de carbostirilo e donepezilo para o tratamento da doença de alzheimer PT2157973E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007135367 2007-05-22

Publications (1)

Publication Number Publication Date
PT2157973E true PT2157973E (pt) 2015-10-14

Family

ID=39636992

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87647798T PT2157973E (pt) 2007-05-22 2008-05-21 Medicamento compreendendo um derivado de carbostirilo e donepezilo para o tratamento da doença de alzheimer

Country Status (27)

Country Link
US (1) US20100298375A1 (enExample)
EP (2) EP2937085B1 (enExample)
JP (1) JP5153870B2 (enExample)
KR (1) KR101441725B1 (enExample)
CN (1) CN101754758B (enExample)
AR (1) AR066664A1 (enExample)
AU (1) AU2008253977B2 (enExample)
BR (1) BRPI0811919A2 (enExample)
CA (1) CA2687289C (enExample)
CO (1) CO6251249A2 (enExample)
CY (1) CY1116683T1 (enExample)
DK (1) DK2157973T3 (enExample)
ES (1) ES2545959T3 (enExample)
HR (1) HRP20150843T1 (enExample)
HU (1) HUE025902T2 (enExample)
IL (1) IL202053A (enExample)
MX (1) MX2009012583A (enExample)
MY (1) MY146407A (enExample)
NZ (1) NZ581099A (enExample)
PL (1) PL2157973T3 (enExample)
PT (1) PT2157973E (enExample)
RU (1) RU2469723C2 (enExample)
SI (1) SI2157973T1 (enExample)
TW (2) TWI423802B (enExample)
UA (1) UA96633C2 (enExample)
WO (1) WO2008143361A1 (enExample)
ZA (1) ZA200908202B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135607A1 (en) 2008-06-18 2009-12-23 Pharnext Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
US9387206B2 (en) 2009-11-03 2016-07-12 Pharnext Therapeutic approaches for treating Alzheimer's disease
EP2322163A1 (en) * 2009-11-03 2011-05-18 Pharnext New therapeutics approaches for treating alzheimer disease
RS53227B (sr) 2011-03-01 2014-08-29 Pharnext Terapija neuroloških poremećaja kombinacijom baklofena i akamprosata
US9248111B2 (en) 2011-03-01 2016-02-02 Pharnext Therapeutic approaches for treating parkinson's disease
US9241933B2 (en) 2011-03-01 2016-01-26 Pharnext Compositions for treating amyotrophic lateral sclerosis
US10010515B2 (en) 2011-03-01 2018-07-03 Pharnext Therapeutic approaches for treating Parkinson's disease
MX2014015310A (es) * 2012-06-15 2015-07-06 Found Biomedical Res & Innov Agente profilactico y/o terapeutico para el deterioro cognoscitivo leve.
WO2015100255A2 (en) * 2013-12-23 2015-07-02 Holaday John W Disposable container for air hydration
US20190142820A1 (en) * 2016-05-19 2019-05-16 National Cerebral And Cardiovascular Center Drug for preventing and/or treating dementia
RS61704B1 (sr) 2017-05-24 2021-05-31 H Lundbeck As Kombinacija antagonista 5-ht6 receptora i inhibitora acetilholinesteraze za upotrebu u lečenju alchajmerove bolesti kod subpopulacije pacijenata koji nose apoe4 alele
CN107602523B (zh) * 2017-09-11 2020-08-18 安徽中医药大学 京尼平类似物、制备方法及其应用
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
NL2024431B1 (en) 2019-12-11 2021-09-07 Sulfateq Bv Compounds for treatment of alzheimer’s disease
CN117797095A (zh) * 2023-11-30 2024-04-02 浙江大学 一种长效脂质液晶植入物及其治疗阿尔茨海默症的用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5649378A (en) 1979-08-25 1981-05-02 Otsuka Pharmaceut Co Ltd Tetrazolylalkoxycarbostyril derivative
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JP2574099B2 (ja) 1992-05-21 1997-01-22 大塚製薬株式会社 アレルギー疾患治療剤
JPH10175864A (ja) 1996-12-16 1998-06-30 Otsuka Pharmaceut Co Ltd 慢性閉塞性肺疾患治療剤
US6322525B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Method of analyzing data from a circulating blood viscometer for determining absolute and effective blood viscosity
US6428488B1 (en) * 1997-08-28 2002-08-06 Kenneth Kensey Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US6322524B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Dual riser/single capillary viscometer
EP1047674B1 (en) * 1998-01-16 2005-03-30 Eisai Co., Ltd. Process for production of donepezil derivatives
US6187790B1 (en) * 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6484565B2 (en) * 1999-11-12 2002-11-26 Drexel University Single riser/single capillary viscometer using mass detection or column height detection
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
TW200301135A (en) * 2001-12-27 2003-07-01 Otsuka Maryland Res Inst Inc Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
US6743806B2 (en) * 2002-10-23 2004-06-01 Otsuka Pharmaceutical Company, Limited Active oxygen scavenger
FR2848452B1 (fr) * 2002-12-12 2007-04-06 Aventis Pharma Sa Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
JP2004189706A (ja) * 2002-12-13 2004-07-08 Eisai Co Ltd 高度アルツハイマー型痴呆治療剤
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener

Also Published As

Publication number Publication date
TWI489983B (zh) 2015-07-01
MY146407A (en) 2012-08-15
HRP20150843T1 (hr) 2015-09-11
IL202053A0 (en) 2010-06-16
EP2937085A1 (en) 2015-10-28
DK2157973T3 (en) 2015-08-17
MX2009012583A (es) 2010-03-08
AU2008253977B2 (en) 2013-08-22
HK1140422A1 (en) 2010-10-15
HK1215384A1 (en) 2016-08-26
ZA200908202B (en) 2010-07-28
AR066664A1 (es) 2009-09-02
IL202053A (en) 2016-04-21
CO6251249A2 (es) 2011-02-21
UA96633C2 (uk) 2011-11-25
CA2687289C (en) 2015-09-15
CY1116683T1 (el) 2017-03-15
US20100298375A1 (en) 2010-11-25
KR101441725B1 (ko) 2014-09-18
RU2009147456A (ru) 2011-06-27
EP2937085B1 (en) 2019-07-10
CA2687289A1 (en) 2008-11-27
WO2008143361A1 (en) 2008-11-27
TW200904428A (en) 2009-02-01
TWI423802B (zh) 2014-01-21
HUE025902T2 (en) 2016-05-30
BRPI0811919A2 (pt) 2014-11-18
ES2545959T3 (es) 2015-09-17
RU2469723C2 (ru) 2012-12-20
CN101754758A (zh) 2010-06-23
TW201412315A (zh) 2014-04-01
NZ581099A (en) 2012-03-30
KR20100020482A (ko) 2010-02-22
SI2157973T1 (sl) 2015-10-30
JP5153870B2 (ja) 2013-02-27
CN101754758B (zh) 2012-10-24
AU2008253977A1 (en) 2008-11-27
EP2157973A1 (en) 2010-03-03
PL2157973T3 (pl) 2015-12-31
EP2157973B1 (en) 2015-07-15
JP2010527993A (ja) 2010-08-19

Similar Documents

Publication Publication Date Title
IL202053A0 (en) A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
EP2091566A4 (en) COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES
EP2151435A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IL195668A0 (en) Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
PL1993365T3 (pl) Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem
IL195574A0 (en) Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia
IL209894A (en) Compounds for the prevention and / or treatment of β-amyloidosis including Alzheimer's disease
PL1965816T3 (pl) Kompozycje farmaceutyczne i sposoby leczenia lub zapobiegania chorobom związanym ze szczawianami
IL208926A0 (en) Use of epothelone d in treating tau-associated diseases including alzheimer's disease
IL212568A (en) Annotated 4,1-Diazepan, Pharmaceutical Preparations Containing Them and Their Uses in the Preparation of Medicines for the Treatment of Diseases or Disorders of Mammals
IL254184B (en) Compositions and methods for treating collagen-mediated diseases
IL194789A0 (en) Terphenyl derivatives for treatment of alzheimer's disease
EP2485733A4 (en) METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP2306824A4 (en) IONTOPHORETIC DELIVERY OF CURCUMINE AND CURCUMINANALOGUE FOR THE TREATMENT OF MORBUS ALZHEIMER
ZA200810528B (en) Procedure and methods for detecting Alzheimer's disease
IL185444A0 (en) Novel drugs for treating respiratory diseases
EP2025667A4 (en) 9, 10-SECOPREGNANDERIVAT AND MEDICINAL PRODUCTS
IL198704A0 (en) Therapeutic compositions and vaccines for treating a tumor or infection
ZA200810199B (en) Rinse-off therapeutic agents for treating skin
EP2565184B8 (en) Therapeutic agent and preventative agent for alzheimer's disease
EP2059238A4 (en) THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS
HUP0600409A3 (en) Izatin and it's derivatives for use as a medicine
TWI341204B (en) Composition and method for prevention and treatment of alzheimer's disease
GB0505237D0 (en) Pharmacological drug therapy for alzheimer's disease
AU2007902117A0 (en) A drug for the treatment of Alzheimer?s disease